NewsRoom Articles - Page 64 of 112 - CanadianCannabisWire

TuesdayJul 09, 2019 11:34 am

Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis

Canada-based Willow Biosciences and U.S.-based Noramco are teaming to biosynthetically produce and market pharmaceutical-grade cannabidiol (CBD) The companies expect to deliver yeast-cultivated CBD as a low-cost, ultra-pure alternative to cannabis cultivation that avoids large-scale plant waste from greenhouse processes Yeast-grown pharmaceutical ingredients have long served as fodder for insulin and other important drugs; the growing interest in cannabis as a therapy is driving a booming new market The sea change in societal attitudes about cannabis, accompanied by the opening of governmental regulatory doors for its use (http://cnw.fm/2FTo9), has spawned a land rush by corporate interests set on staking out market territory…

TuesdayJul 09, 2019 11:01 am

Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License

Geyser Brands is a cannabis consumer wellness company dedicated to helping people look, feel and do their best The company announced June 18 that wholly owned subsidiary Apothecary Botanicals has been awarded a processing license, allowing GYSR to advance its brands Geyser’s LOI to acquire Solace Management Group is expected to give the company additional wellness brands for humans and their pets, once due diligence is completed Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is moving forward with its vision of developing premier cannabis-enhanced products following Health Canada’s announcement that the company’s wholly owned subsidiary, Apothecary Botanicals (0957102…

TuesdayJul 09, 2019 10:38 am

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Consumer Access with Retail Partnerships for CBD Product Lines

Wildflower Brands has completed a distribution deal that places its CBD-based SKUs at nearly 300 Dillard’s stores nationwide Wildflower’s products are also being sold through bohemian lifestyle outlet Free People, which is labeling the products as part of its Beauty and Wellness Collection Wildflower’s success has led to the hiring of a second shift of employees at its Washington production facility and the start of construction of a new facility to keep pace with demand Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is getting its cannabis-based wellness products into an expanding number of consumers’ hands through retail partnerships that are…

MondayJul 08, 2019 10:11 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment

Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria is helping firms meet supply and demand requirements by creating products that offer lower dosing with higher absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is known for its innovative delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. The company developed drug-delivery platform DehydraTECH and out-licenses the platform to create new (and improve existing) orally ingested…

WednesdayJul 03, 2019 10:59 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Closes Initial Share Purchase of Cannova Medical Ltd.

Nabis Holdings has closed on its previously announced initial purchase of a 49 percent interest in Cannova Medical Ltd., with an option to purchase the remaining 51 percent The company selected Cannova Medical for its unique approach to consumable cannabis technology and untapped industry potential Nabis sees Cannova as a potential disruptor in the edible cannabis industry Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company pursuing specialty investment opportunities in the burgeoning cannabis industry (among others), recently announced that it has now completed the purchase of a 49 percent interest in Cannova Medical Ltd.,…

TuesdayJul 02, 2019 11:20 am

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Readies for Canada’s Second Cannabis Wave with Successful Run of APP Extraction Process

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids Deloitte estimates that Canada’s cannabis edibles and topicals market could be worth $2.7 billion annually The company has entered into an exclusive joint venture with Moosehead Breweries Limited to develop and produce nonalcoholic, cannabis-infused beverages Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) has reached another milestone by successfully completing the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc., Sproutly CEO and Director Keith Dolo announced in a news release (http://cnw.fm/kQP6M).…

TuesdayJul 02, 2019 10:37 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Enhanced DehydraTECH Delivers More CBD into the Body

The new version of the DehydraTECH delivery platform is suitable for use in pills, capsules and tablets for the pharmaceutical, medical and supplement markets DehydraTECH has demonstrated that it can deliver eight times more CBD into the blood than standard industry formulations Animal testing shows that combining DehydraTECH with a nanoemulsion formulation greatly assists delivery of cannabinoids and nicotine across the blood-brain barrier Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) new enhanced version of its patented delivery technology, DehydraTECH, has demonstrated that it can deliver eight-times more CBD into the blood and 19-times more CBD into the brain tissue than…

MondayJul 01, 2019 1:17 pm

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Celebrates Cannabis Shipment to 10th Canadian Province

Organigram is in a sharp growth pattern as the company builds toward its production capacity target of 113,000 kilograms of cannabis per year at its New Brunswick campus The company’s recent announcement of Health Canada’s licensing approval for an additional 17 cultivation rooms brings total licensed target production capacity to 61,000 kg per year The company announced a shipment of product to Quebec in June, marking its official fulfillment of an order to the last of Canada’s 10 provinces and establishment of its coast-to-coast network Organigram is also refurbishing its Moncton Campus for its own edibles facility and additional in-house…

FridayJun 28, 2019 11:31 am

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Pursuing Development of a Global Cannabis Marketplace

TransCanna recently acquired a 196,000 sq. ft cannabis-concentrated hub in Stanislaus County, California, in keeping with its expansion plans to develop a global cannabis marketplace It also received gross aggregate proceeds of more than C$10 million in private placement funding, which is being used for equipment purchase, acquisitions and other business activities The company has hired a new general manager, Alan R. Applonie, who has decades of infrastructure experience working with Amazon, Starbucks, Walmart, 7-Eleven and Kroger TransCanna is aiming to buy and develop 15 premium cannabis brands in California TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) is a Canadian…

FridayJun 28, 2019 10:52 am

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches Investment Platform Focused on Cannabis Industry

Supreme Heights will focus on opportunities in the UK and European CBD health and wellness space The investment platform will benefit from Supreme Cannabis’ vast industry experience and connected leadership team Supreme Cannabis’ CEO expects the move to enhance revenue value for investors The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading Canadian cannabis producer, recently announced its launch of Supreme Heights, a new investment platform. Supreme Heights, established in London, will take advantage of opportunities within the United Kingdom and Europe’s CBD health and wellness sector. While Supreme Heights has been initiated as a separate…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977